Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Dursun, Polat ^a   Senger, Süheyla S ^a,b   Arslan, Hande ^a,b   Kuşçu, Esra ^a   Ayhan, Ali ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b Sect Infect Dis Hacettepe U   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GYNECOLOGICAL EXAMINATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 67; HUMAN PAPILLOMAVIRUS TYPE 81; HUMAN PAPILLOMAVIRUS TYPE 90; MAJOR CLINICAL STUDY; OUTPATIENT; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREVALENCE; RETROSPECTIVE STUDY; SPECIES DISTRIBUTION; TURKEY (REPUBLIC); UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS; AGE; CLASSIFICATION; GENETICS; GENOTYPE; MIDDLE AGED; OUTPATIENT DEPARTMENT; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; STATISTICS; UTERINE CERVIX; UTERINE CERVIX DISEASE; VAGINA SMEAR; VIROLOGY;

ADULT; AGE FACTORS; AGED; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; RETROSPECTIVE STUDIES; TURKEY; UTERINE CERVICAL DISEASES; VAGINAL SMEARS; YOUNG ADULT;

EID: 71949085756     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-191     Document Type: Article

References (28)

1. Bulletin of the World Health Organization (BLT) World Health Organization Web site. , http://www.who.int/bulletin/volumes/84/2/
2. Turkish national cancer advisory board. , http://ukdk.org/pdf/kitap/en/30.pdf
3. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S, . IARC HPV Prevalence Surveys Study Group Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005, 366(9490):991-8. 10.1016/S0140-6736(05)67069-9, 16168781.
4. Inal MM, Köse S, Yildirim Y, Ozdemir Y, Töz E, Ertopçu K, Ozelmas I, Tinar S. The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women. Int J Gynecol Cancer 2007, 17(6):1266-70. Epub 2007 Apr 18, 10.1111/j.1525-1438.2007.00944.x, 17442019.
5. Tuncer ZS, Basaran M, Ustaçelebi S, Kuzey GM. High-Risk Human Papilloma Virus (HPV) Infection Determined By Hybrid Capture II Assay in a Turkish University Hospital Outpatient Clinic MN-Gorm. 2006, 12(2):129-134.
6. Ozçelik B, Serin IS, Gökahmetoǧlu S, Başbuǧ M, Erez R. Human papillomavirus frequency of women at low risk of developing cervical cancer: a preliminary study from a Turkish university hospital. Eur J Gynaecol Oncol 2003, 24(2):157-9.
7. Seçkin S, Aksoy F, Yi{dotless}ldi{dotless}ri{dotless}m M. Servikal Smearlerde HPV İnfeksiyonu Görülme İndisansi{dotless}. Ankara Numune Eǧitim ve Araşti{dotless}rma Hastanesi Ti{dotless}p Dergisi 1996, 36(1-2-3-4):101-103.
8. Safi Z, Demirezen S, Beksaç MS, Kuzey GM, Kocagöz T, Ustaçelebi T, Hasçelik G, Çakar A. İnsan Papilloma Virusunun (IPV) Polimeraz Zincir Reaksiyonu Tekniǧi İle Servikal Ve Vajinal Aki{dotless}nti{dotless} Örneklerinde Saptanmasi{dotless}. Mn-Klinik Bilimler&Doktor 2002, 8(1):112-114.
9. Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K. Distribution of Human Papillomavirus Types in ThinPrep Papanicolaou Tests Classified According to the Bethesda 2001 Terminology and Correlations with Patient Age and Biopsy Outcomes. Cancer 2006, 106:1054-64. 10.1002/cncr.21664, 16421920.
10. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005, 162:199-200. 10.1093/aje/kwi188, 15987728.
11. Lee J, Tan CS, Chia KS. A practical guide for multivariate analysis of dichotomous outcomes. Ann Acad Med Singapore 2009, 38(8):714-9.
12. Parkin DM, Bray F. The burden of HPV-related cancers. Vaccine 2006, 24(Suppl 3):S11-S25.
13. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006, 118:3030-44. 10.1002/ijc.21731, 16404738.
14. Prevalence of Abnormal Cervical Cytology in Turkey A Turkish Gynecologic Oncology Group study. Turkish Cervical Cancer and Cervical Cytology Research Group. Int J Gynaecol Obstet 2009, 106(3):206-9. 10.1016/j.ijgo.2009.04.003, 19541303.
15. Dursun P, Altuntas B, Kuscu E, Ayhan A. Women's Knowledge about Human Papilloma Virus (HPV) and Their Acceptance of HPV Vaccine. Aust N Z J Obstet Gynaecol 2009, 49(2):202-6. 10.1111/j.1479-828X.2009.00947.x, 19432612.
16. Bao YP, Li N, Smith JS, Qiao YL, . ACCPAB members Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer 2008, 18(1):71-9. Epub 2007 Apr 26.
17. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7(7):453-9. 10.1016/S1473-3099(07)70158-5, 17597569.
18. González-Bosquet E, Esteva C, Muñoz-Almagro C, Ferrer P, Pérez M, Lailla JM. Identification of vaccine human papillomavirus genotypes in squamous intraepithelial lesions (CIN2-3). Gynecol Oncol 2008, 111(1):9-12. Epub 2008 Aug 5, 10.1016/j.ygyno.2008.06.012, 18684497.
19. Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A. Human papillomavirus (HPV) testing in the management of women with abnormal pap smears. Experience of a colposcopy referral clinic. Eur J Gynaec Oncol 2004, 25:577-84.
20. Rowe LR, Aldeen W, Bentz JS. Prevalence and typing of HPV by hybrid capture in women with ASCUS, ASC-H and AGC on ThinPrep Pap test. Diagn Cytopathol 2004, 30:426-32. 10.1002/dc.20052, 15176032.
21. González Bosquet E, Muñoz Almagro MM, Mora I, Suñol M, Callejo J, Lailla JM. Prevalence of human papilloma virus infection of the uterine cervix in women with abnormal cervical cytology. Eur J Gynaecol Oncol 2006, 27(2):135-8.
22. Levert M, Clavel C, Graesslin O, Masure M, Birembaut P, Quereux C. Human papillomavirus typing in routine cervical smears. Result from a series of 3778 patients. Gynecol Obstet Fertil 2000, 28:722-8. 10.1016/S1297-9589(00)00011-4, 11244634.
23. Hwang HS, Park M, Lee SY, Kwon KH, Pang MG. Distribution and Prevalence of Human Papillomavirus Genotypes in Routine Pap Smear of 2,470 Korean Women Determined by DNA Chip. Cancer Epidemiol Biomarkers Prev 2004, 13(12):2153-6.
24. Arora R, Kumar A, Prusty BK, Kailash U, Batra S, Das BC. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear. Eur J Obstet Gynecol Reprod Biol 2005, 121(1):104-9. 10.1016/j.ejogrb.2004.11.025, 15950365.
25. Woodman CB, Collins S, Winter H. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001, 357(9271):1831-6. 10.1016/S0140-6736(00)04956-4, 11410191.
26. Sellors JW, Mahony JB, Kaczorowski J. Prevalence and predictors of human papilloma virus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 2000, 163:503-8. 80454, 11006760.
27. Burk RD, Kelly P, Feldman J. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996, 23:333-341.
28. Onan MA, Taskiran C, Bozdayi G, Biri A, Erdem O, Acar A, Gunaydin G, Rota S, Ataoglu O, Guner H. Assessment of human papilloma viral load of archival cervical intraepithelial neoplasia by real-time polymerase chain reaction in a Turkish population. Eur J Gynaecol Oncol 2005, 26(6):632-5.